ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 79 filers reported holding ARCUS BIOSCIENCES INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $563,253 | -10.9% | 31,379 | +0.9% | 0.00% | 0.0% |
| Q2 2023 | $631,864 | +15.3% | 31,111 | +3.6% | 0.00% | 0.0% |
| Q1 2023 | $547,784 | -8.9% | 30,032 | +3.3% | 0.00% | 0.0% |
| Q4 2022 | $601,354 | -14.6% | 29,079 | +8.1% | 0.00% | 0.0% |
| Q3 2022 | $703,939 | +12.3% | 26,909 | +8.7% | 0.00% | -50.0% |
| Q2 2022 | $627,000 | +12.4% | 24,758 | +40.0% | 0.00% | +100.0% |
| Q1 2022 | $558,000 | -22.0% | 17,678 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $715,000 | +13.9% | 17,678 | -1.8% | 0.00% | 0.0% |
| Q3 2021 | $628,000 | +27.1% | 18,010 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $494,000 | -4.8% | 18,010 | -2.6% | 0.00% | 0.0% |
| Q1 2021 | $519,000 | +8.6% | 18,490 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $478,000 | +96.7% | 18,429 | +30.1% | 0.00% | 0.0% |
| Q3 2020 | $243,000 | -14.1% | 14,166 | +23.7% | 0.00% | 0.0% |
| Q2 2020 | $283,000 | +20.9% | 11,456 | -31.9% | 0.00% | 0.0% |
| Q1 2020 | $234,000 | +37.6% | 16,828 | 0.0% | 0.00% | – |
| Q4 2019 | $170,000 | +25.9% | 16,828 | +13.1% | 0.00% | – |
| Q3 2019 | $135,000 | +14.4% | 14,875 | 0.0% | 0.00% | – |
| Q2 2019 | $118,000 | -27.2% | 14,875 | +14.8% | 0.00% | – |
| Q1 2019 | $162,000 | +16.5% | 12,952 | 0.0% | 0.00% | – |
| Q4 2018 | $139,000 | – | 12,952 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |